Search Results
Jun 19, 2026, 22:00 ET PicS N.V. Notice of August 4, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
https://www.ksfcounsel.com/cases/nasdaqgs-pics/?prs=prnPicS investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (
More news about: Kahn Swick & Foti, LLC
Jun 19, 2026, 22:00 ET Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
https://www.ksfcounsel.com/cases/nasdaqgs-srad/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by July 17,
More news about: Kahn Swick & Foti, LLC
Jun 19, 2026, 22:00 ET GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
https://www.ksfcounsel.com/cases/nasdaqgs-wgs/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by August
More news about: Kahn Swick & Foti, LLC
Jun 19, 2026, 22:00 ET SES AI Corporation Securities Fraud Class Action Result of Weak Revenue Guidance and 37% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
https://www.ksfcounsel.com/cases/nyse-ses/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 26,
More news about: Kahn Swick & Foti, LLC
Jun 19, 2026, 22:00 ET Activision Blizzard, Inc. Notice of June 30, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
https://www.ksfcounsel.com/cases/nasdaqgm-atvi/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 30,
More news about: Kahn Swick & Foti, LLC
Jun 19, 2026, 22:00 ET Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
https://www.ksfcounsel.com/cases/nyse-via/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by August 10,
More news about: Kahn Swick & Foti, LLC
Jun 18, 2026, 10:01 ET MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
published a paper in Plastic and Reconstructive Surgery (PRS 2026) examining the portability and ergonomic advantages of 3D exoscopes equipped with heads-up displays – SHIYA's core offering. Their findings
More news about: MediThinQ
Jun 18, 2026, 10:01 ET MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
published a paper in Plastic and Reconstructive Surgery (PRS 2026) examining the portability and ergonomic advantages of 3D exoscopes equipped with heads-up displays – SHIYA's core offering. Their findings
More news about: MediThinQ
Jun 18, 2026, 08:29 ET Sensodyne expands oral care portfolio with Pronamel Kids for enamel care and 24hr cavity protection*
the everyday health of consumers. In India, our portfolio spans key categories including Oral Health, Digestive Health, Pain Relief and Respiratory (PRS), and Vitamins, Minerals and Supplements (VMS) with superior brands such as Sensodyne, Eno, Otrivin, Centrum, Iodex, Crocin, Parodontax and Ostocalcium.
More news about: Haleon India
Jun 18, 2026, 08:04 ET New Constructs Joins JOTO PR Disruptors™ to Advance Transparent Investment Research in AI Era
unverifiable data, they can scale misinformation just as quickly as they scale insight. That is not a stock story. It is a market-integrity story."JOTO PR's Anti-PR® strategy will position New Constructs as a leading authority on transparent investment research, AI accountability in finance, financial data
More news about: JOTO PR
Jun 17, 2026, 21:15 ET Greenberg Traurig Named The Lawyer Awards 2026 Real Estate Team of the Year
Fund, advised by Waypoint Asset Management, and the fund's £1.1 billion take-private acquisition of The PRS REIT plc, which underscored the firm's leadership in the U.K.'s residential sector. The PRS REIT portfolio comprises almost 5,500 single-family homes across 71 sites throughout the U.K., making the
More news about: Greenberg Traurig, LLP
Jun 17, 2026, 12:44 ET Ron Simon & Associates Files First Botulism Lawsuit Against Nara Organics in Riverside County, California, on Behalf of a 3-Month-Old Infant
Stephanie and Ian Roltsch, who was diagnosed with infant botulism after consuming the product. Target, the retailer, was also named in the suit. PR's parents fed the formula to their son, but soon noted the effects of botulism poisoning and took him in for emergency medical treatment. After becoming
More news about: Ron Simon & Associates
Jun 17, 2026, 08:01 ET Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
active dose levels of NTX1088 (1200 and 1750 mg) in combination with pembrolizumab (200 mg). Among 41 evaluable patients, confirmed partial responses (PRs) were observed across multiple tumor types, including gastric, bladder, non-small cell lung cancer, squamous cell carcinoma of the head and neck, and
More news about: Nectin Therapeutics, LTD.
Jun 16, 2026, 08:05 ET When Stitches Act Like Saws: Florida Surgeons Publish New Strategy for Severe Muscle Injuries
Plastic Surgery Trauma Associates announces publication in PRS Global Open of a scaffold-based repair technique developed for severe muscle injuries where stitches may cut through damaged tissue rather than hold it. In early clinical use, a first responder treated with SMART returned to duty after
More news about: Plastic Surgery Trauma Associates
Jun 13, 2026, 23:00 ET Zillow Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Zillow Group, Inc. - ZG, Z
https://claimsfiler.com/cases/nasdaq-z-3/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 12, 2026, 23:00 ET SES AI Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against SES AI Corporation - SES
https://claimsfiler.com/cases/nyse-ses/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
https://claimsfiler.com/cases/nasdaq-adma-1/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET Sportradar Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Sportradar Group AG - SRAD
https://claimsfiler.com/cases/nasdaq-srad/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET Via Transportation Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Via Transportation, Inc. - VIA
https://claimsfiler.com/cases/nyse-via/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
https://www.claimsfiler.com/cases/nasdaq-wgs/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 12, 2026, 22:00 ET PicS Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PicS N.V. - PICS
https://claimsfiler.com/cases/nasdaq-pics/?prs=prn or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.About
More news about: ClaimsFiler
Jun 11, 2026, 08:06 ET HousMthr Joins JOTO PR Disruptors™ to Replace the Chaotic Group Trip Text
unpaid trip manager, accountant, reminder system, safety contact and decision-maker. That invisible labor is where the real friction lives."JOTO PR's proprietary Anti-PR® strategy will establish HousMthr as a leading authority in AI-native group travel coordination, after-booking execution, and Group
More news about: JOTO PR
Jun 11, 2026, 04:30 ET Haleon Announces ~₹2000 Crore Total Investment to Set Up its First Manufacturing Facility in India
the everyday health of consumers. In India, our portfolio spans key categories including Oral Health, Digestive Health, Pain Relief and Respiratory (PRS), and Vitamins, Minerals and Supplements (VMS) with superior brands such as Sensodyne, Eno, Otrivin, Centrum, Iodex, Crocin, Parodontax and Ostocalcium.
More news about: Haleon India
Jun 11, 2026, 02:20 ET CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
non-squamous ORR 75%, consistent benefit;Earlier data (March 2026) showed 9 PRs out of 10 patients; among the 6 newly enrolled patients, 4 achieved a PR at their first tumor assessment, bringing the total number of PRs observed to 13;No responding patients have experienced rapid disease progression,
More news about: CStone Pharmaceuticals
Jun 08, 2026, 00:41 ET Everything-PR Names the 100 People Shaping What AI Engines Say
ownership. Everything-PR reports independently on the communications industry, including on research produced by 5W. Editorial decisions are made by Everything-PR's editorial team. Everything-PR does not accept payment for inclusion on the AI Communications 100.Media ContactEverything-PR
More news about: 5W Public Relations